Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

129 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Peripheral versus central potencies of N-type voltage-sensitive calcium channel blockers.
Wang YX, Bezprozvannaya S, Bowersox SS, Nadasdi L, Miljanich G, Mezo G, Silva D, Tarczy-Hornoch K, Luther RR. Wang YX, et al. Among authors: Luther RR. Naunyn Schmiedebergs Arch Pharmacol. 1998 Feb;357(2):159-68. doi: 10.1007/pl00005150. Naunyn Schmiedebergs Arch Pharmacol. 1998. PMID: 9521489
Blocking potencies (IC50s) in the tail artery assay were significantly correlated with those measured in the hippocampal slice preparation (r = 0.91, P = 0.00000012). ...Blockade of hippocampal norepinephrine release was not significantly correlated with the inhibition of …
Blocking potencies (IC50s) in the tail artery assay were significantly correlated with those measured in the hippocampal slice preparation ( …
Ziconotide, a new N-type calcium channel blocker, administered intrathecally for acute postoperative pain.
Atanassoff PG, Hartmannsgruber MW, Thrasher J, Wermeling D, Longton W, Gaeta R, Singh T, Mayo M, McGuire D, Luther RR. Atanassoff PG, et al. Among authors: Luther RR. Reg Anesth Pain Med. 2000 May-Jun;25(3):274-8. doi: 10.1016/s1098-7339(00)90010-5. Reg Anesth Pain Med. 2000. PMID: 10834782 Clinical Trial.
Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial.
Staats PS, Yearwood T, Charapata SG, Presley RW, Wallace MS, Byas-Smith M, Fisher R, Bryce DA, Mangieri EA, Luther RR, Mayo M, McGuire D, Ellis D. Staats PS, et al. Among authors: Luther RR. JAMA. 2004 Jan 7;291(1):63-70. doi: 10.1001/jama.291.1.63. JAMA. 2004. PMID: 14709577 Clinical Trial.
129 results
Jump to page
Feedback